Ribofunk science fiction writer Paul Di Filippo rounds up the big picture on transgenic plants and animals for Contract Pharma magazine:
Meanwhile, at GTC Biotherapeutics in Framingham, MA, goats seem to be the ideal solution to that company's particular quest. And certainly this choice of caprine platform has paid off enormously; GTC can now boast a historical milestone with the release of "ATryn®, our recombinant form of human antithrombin, the first transgenically produced protein to be approved anywhere in the world, having recently been approved by the European Commission for the prophylactic treatment of deep vein thrombosis in patients with hereditary antithrombin deficiencies that are undergoing surgical procedures," according to a company statement.
(Thanks, Paul!)
